Lung Cancer News and Research

Latest Lung Cancer News and Research

Tobacco companies finally own up to cigarette smoking risks

It has been a decade since federal courts have found tobacco companies to be deceiving the general public by hiding the exact level of risk associated with cigarette smoking. Now finally the tobacco companies have agreed to own up the risks and air a set of advertisements on television and newspapers to correct the statements they have been making until now.

27 Nov 2017

Researchers question exclusion of people with prior cancer history from clinical trials

A quarter of newly diagnosed cancer patients 65 or older are survivors who had a prior cancer – often preventing them from participating in clinical trials, researchers from UT Southwestern's Simmons Cancer Center have found.

22 Nov 2017

Inflammatory processes triggered by lung cancer could cause pulmonary hypertension

Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung cancer patients. These symptoms can be triggered by pulmonary hypertension, as scientists at the Max Planck Institute for Heart and Lung Research in Bad Nauheim and the German Center for Lung Research found after examining more than 500 patients.

22 Nov 2017

KAIST researchers identify principles of gene network for colon tumorigenesis

The principles of the gene network for colon tumorigenesis have been identified by a KAIST research team. The principles will be used to find the molecular target for effective anti-cancer drugs in the future. Further, this research gained attention for using a systems biology approach, which is an integrated research area of IT and BT.

20 Nov 2017

Study: Alectinib 600 mg more effective than standard therapy in Asian ALK positive NSCLC patients

A subanalysis of the phase III ALEX study has shown that alectinib 600 mg twice daily is more effective than standard of care crizotinib in Asian patients with anaplastic lymphoma kinase (ALK) positive non-small-cell lung cancer (NSCLC), researchers report at the ESMO Asia 2017 Congress.

20 Nov 2017

Osimertinib provides progression-free survival benefit to Asian patients with EGFR-mutated NSCLC

Osimertinib improves progression-free survival compared to standard first line therapy in Asian patients with EGFR-mutated non-small-cell lung cancer (NSCLC), according to the Asian subset analysis of the FLAURA trial presented at the ESMO Asia 2017 Congress, sumultaneously published in The New England Journal of Medicine.

20 Nov 2017

ATS debuts new video to highlight dangers of flavored tobacco

Educating the public about the dangers of tobacco addiction has long been a priority for the American Thoracic Society, which provides scientifically-supported arguments to counter Big Tobacco's marketing and lobbying efforts.

16 Nov 2017

Changes in multiple different genes drive world's most deadly forms of lung cancer

A new UC San Francisco–led study challenges the dogma in oncology that most cancers are caused by one dominant "driver" mutation that can be treated in isolation with a single targeted drug. Instead, the new research finds one of the world's most deadly forms of lung cancer is driven by changes in multiple different genes, which appear to work together to drive cancer progression and to allow tumors to evade targeted therapy.

15 Nov 2017

Diet, smoking and alcohol main causes of death in OECD countries

The “Health at a Glance” report 2017 shows that over 10 million deaths have been recorded in the OECD countries in 2015. Thus the number of deaths on an average in these countries is 793 per 100,000 population.

13 Nov 2017

Elevated levels of chronic stress hormones may promote EGFR inhibitor resistance in NSCLC patients

Elevated levels of chronic stress hormones, such as those produced by psychological distress, may promote resistance to drugs commonly used to treat lung cancer patients with EGFR mutations, according to new research from The University of Texas MD Anderson Cancer Center.

9 Nov 2017

Novel mathematical model can predict how cancer patient will benefit from immunotherapies

Researchers at the Icahn School of Medicine at Mount Sinai have created the first mathematical model that can predict how a cancer patient will benefit from certain immunotherapies, according to a study published in Nature.

9 Nov 2017

Novel approach could help predict how well patients respond to cancer treatment

A novel approach developed by researchers from the University of Leicester and the MRC Toxicology Unit could help to predict how well patients respond to drugs designed to fight various forms of cancer.

8 Nov 2017

New category of immunotherapy appears safe to use in patients with both cancer and HIV

A new category of immunotherapies called checkpoint inhibitors that has been highly effective against many different cancers appears safe to use in patients with both advanced malignancies and HIV, a population excluded from earlier trials of such therapies, according to an early-phase trial.

7 Nov 2017

FDG PET/CT imaging shows correlation between amount of cfDNA and cancer aggressiveness

Italian researchers have demonstrated a better way of determining the aggressiveness of tumors in patients with advanced non-small cell lung cancer (NSCLC).

7 Nov 2017

Gut bacteria may influence the response to certain cancer therapies finds study

A latest study has found that patients with advanced melanoma or skin cancer who had a specific bacteria in their gut had a more favorable response to certain types of cancer treatment or immunotherapy. The study from the University of Texas was published in the latest issue of the journal Science.

3 Nov 2017

Dinosaur extinction metal can be used to kill cancer cells

Cancer cells can be targeted and destroyed with the metal from the asteroid that caused the extinction of the dinosaurs, according to new research by an international collaboration between the University of Warwick and Sun Yat-Sen University in China.

2 Nov 2017

Experts highlight importance of early lung cancer screening

Lung cancer is the second most common cancer in both men and women, and is by far the leading cause of cancer death among both men and women. In 2017, the American Cancer Society estimates more than 200,000 new cases of lung cancer will be diagnosed in the United States, with more than 150,000 deaths.

1 Nov 2017

Air pollution linked to mortality from kidney, bladder and colorectal cancer

Air pollution is classified as carcinogenic to humans given its association with lung cancer, but there is little evidence for its association with cancer at other body sites. In a new large-scale prospective study led by the Barcelona Institute of Global Health, an institution supported by the "la Caixa" Foundation, and the American Cancer Society, researchers observed an association between some air pollutants and mortality from kidney, bladder and colorectal cancer.

31 Oct 2017

SU2C and its collaborators announce four teams to intercept cancer at earliest stages

Stand Up To Cancer, joined by the Lustgarten Foundation for Pancreatic Cancer Research, LUNGevity, and the American Lung Association, announced today four teams of top researchers who will carry out an attack on cancers of the lung and pancreas using a radical new approach of “interception” of cancers at very early stages, when they can be more successfully treated.

31 Oct 2017

Canadian and Israeli researchers join forces for new research program

The Joint Canada-Israel Health Research Program is a seven-year, CA$35 million partnership between the Azrieli Foundation, Canada's International Development Research Centre, the Canadian Institutes of Health Research, and the Israel Science Foundation that draws on the scientific strengths of Canadian and Israeli researchers in the broad field of biomedicine.

30 Oct 2017

Lung Cancer News and Research

Latest Lung Cancer News and Research

Tobacco companies finally own up to cigarette smoking risks

Researchers question exclusion of people with prior cancer history from clinical trials

Inflammatory processes triggered by lung cancer could cause pulmonary hypertension

KAIST researchers identify principles of gene network for colon tumorigenesis

Study: Alectinib 600 mg more effective than standard therapy in Asian ALK positive NSCLC patients

Osimertinib provides progression-free survival benefit to Asian patients with EGFR-mutated NSCLC

ATS debuts new video to highlight dangers of flavored tobacco

Changes in multiple different genes drive world's most deadly forms of lung cancer

Diet, smoking and alcohol main causes of death in OECD countries

Elevated levels of chronic stress hormones may promote EGFR inhibitor resistance in NSCLC patients

Novel mathematical model can predict how cancer patient will benefit from immunotherapies

Novel approach could help predict how well patients respond to cancer treatment

New category of immunotherapy appears safe to use in patients with both cancer and HIV

FDG PET/CT imaging shows correlation between amount of cfDNA and cancer aggressiveness

Gut bacteria may influence the response to certain cancer therapies finds study

Dinosaur extinction metal can be used to kill cancer cells

Experts highlight importance of early lung cancer screening

Air pollution linked to mortality from kidney, bladder and colorectal cancer

SU2C and its collaborators announce four teams to intercept cancer at earliest stages

Canadian and Israeli researchers join forces for new research program

The ultimate guide to lung research tools and protocols eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Lung Cancer News and Research

Latest Lung Cancer News and Research

The ultimate guide to lung research tools and protocols eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in